OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanisms of Pharmaceutical Therapy and Drug Resistance in Esophageal Cancer
Chengyi Mao, Xiaoxi Zeng, Chao Zhang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Esophageal cancer: emerging therapeutics
Jane E. Rogers, Matheus Sewastjanow‐Silva, Rebecca Waters, et al.
Expert Opinion on Therapeutic Targets (2022) Vol. 26, Iss. 2, pp. 107-117
Closed Access | Times Cited: 107

Uncovering the role of microRNAs in esophageal cancer: from pathogenesis to clinical applications
Zhenglin He, Yanhong Ji, Yutong Yuan, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access

Recent advances in the role of circRNA in cisplatin resistance in tumors
Jiawen Zhang, Qiwen Yu, Weijin Zhu, et al.
Cancer Gene Therapy (2025)
Closed Access

Extracellular vesicle‐LncRNA HOTAIR modulates esophageal cancer chemoresistance and immune microenvironment via miR‐375/CDH2 pathway
Tayier Tuersong, Munire Shataer, Yan Chen, et al.
Journal of Cell Communication and Signaling (2025) Vol. 19, Iss. 2
Open Access

KIF18A knockdown reduces proliferation, migration, invasion and enhances radiosensitivity of esophageal cancer
Luxi Qian, Xiang Cao, Mingyu Du, et al.
Biochemical and Biophysical Research Communications (2021) Vol. 557, pp. 192-198
Open Access | Times Cited: 23

Splicing factor TRA2A contributes to esophageal cancer progression via a noncanonical role in lncRNA m6A methylation
Mingrong Bei, Shijia Hao, Kai Lin, et al.
Cancer Science (2023) Vol. 114, Iss. 8, pp. 3216-3229
Open Access | Times Cited: 8

Long noncoding RNA SNHG6 silencing sensitized esophageal cancer cells to 5-FU via EZH2/STAT pathway
Ran Tan, Jia Liu, Jiang Wang, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 7

Serine/threonine‐protein kinase D2‐mediated phosphorylation of DSG2 threonine 730 promotes esophageal squamous cell carcinoma progression
Yin‐Qiao Liu, Yi‐Wei Xu, Zheng‐Tan Zheng, et al.
The Journal of Pathology (2024) Vol. 263, Iss. 1, pp. 99-112
Closed Access | Times Cited: 2

Thymol Enhances 5-Fluorouracil Cytotoxicity by Reducing Migration and Increasing Apoptosis and Cell Cycle Arrest in Esophageal Cancer Cells: An In-vitro Study
Ghazaleh pouyamanesh, Nima Ameli, Yekta Metanat, et al.
Indian Journal of Clinical Biochemistry (2024)
Closed Access | Times Cited: 2

Personalized mRNA vaccine combined with PD-1 inhibitor therapy in a patient with advanced esophageal squamous cell carcinoma
Bin Wang, Xiaobo Peng, Jie Li, et al.
American Journal of Cancer Research (2024) Vol. 14, Iss. 8, pp. 3896-3904
Closed Access | Times Cited: 2

Reticulocalbin3: A Ca2+ homeostasis regulator that promotes esophageal squamous cell carcinoma progression and cisplatin resistance
Rui Cai, Ping Wang, Xin Zhao, et al.
Cancer Science (2022) Vol. 113, Iss. 10, pp. 3593-3607
Open Access | Times Cited: 10

YAP inhibitor verteporfin suppresses tumor angiogenesis and overcomes chemoresistance in esophageal squamous cell carcinoma
Xuewei Wang, Rong Zhao, Ziyi Yang, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 10, pp. 7703-7716
Closed Access | Times Cited: 6

The Role of lncRNA PCAT6 in Cancers
Siying Wang, Zhenyao Chen, Jingyao Gu, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 14

Identification of ERCC8 as a novel cisplatin-resistant gene in esophageal cancer based on genome-scale CRISPR/Cas9 screening
Xue Sui, Xiaolong Tang, Xi Wu, et al.
Biochemical and Biophysical Research Communications (2022) Vol. 593, pp. 84-92
Closed Access | Times Cited: 8

GDF15 negatively regulates chemosensitivity via TGFBR2-AKT pathway-dependent metabolism in esophageal squamous cell carcinoma
Yingxi Du, Yarui Ma, Qing Zhu, et al.
Frontiers of Medicine (2022) Vol. 17, Iss. 1, pp. 119-131
Closed Access | Times Cited: 8

Clinical and Prognostic Impact of the Warburg Effect in Esophageal Carcinoma: Monocarboxylate Transporters as Candidates for Therapeutic Targeting
Julieta Afonso, Andreia Barbosa, Paula Roberta Aguiar Pastrez, et al.
Pathobiology (2023) Vol. 90, Iss. 4, pp. 251-269
Closed Access | Times Cited: 3

The critical role of circular RNAs in drug resistance in gastrointestinal cancers
Sadra Samavarchi Tehrani, Fataneh Esmaeili, Moein Shirzad, et al.
Medical Oncology (2023) Vol. 40, Iss. 4
Closed Access | Times Cited: 3

Curcumin inhibits esophageal squamous cell carcinoma progression through down‐regulating the circNRIP1/miR‐532‐3p/AKT pathway
Tianxia Luo, Hongya Guan, Jia Liu, et al.
Environmental Toxicology (2023) Vol. 38, Iss. 11, pp. 2705-2716
Closed Access | Times Cited: 3

TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis
Qianqian Ju, Wenjing Sheng, Meichen Zhang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Identification of key genes and pathways involved in T-DM1-resistance in OE-19 esophageal cancer cells through bioinformatics analysis
Fateme Yazdani, Negar Mottaghi-Dastjerdi, Behzad Shahbazi, et al.
Heliyon (2024) Vol. 10, Iss. 18, pp. e37451-e37451
Open Access

Page 1 - Next Page

Scroll to top